Deracoxib

Deracoxib

Clinical data
Trade names	Deramaxx
AHFS/Drugs.com	International Drug Names
Routes of administration	Oral
ATCvet code	QM01AH94 (WHO)
Legal status
Legal status	Veterinary use only
Pharmacokinetic data
Protein binding	High (more than 90%)
Metabolism	Hepatic biotransformation
Elimination half-life	3 hours at 2–3 mg/kg
Excretion	In feces
Identifiers
IUPAC name 4-[3-(Difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazole-1-yl] benzenesulfonamide
CAS Number	169590-41-4 N
PubChem CID	3058754
ChemSpider	2319853 Y
UNII	VX29JB5XWV
ChEBI	CHEBI:73032 N
ChEMBL	ChEMBL28636 Y
CompTox Dashboard (EPA)	DTXSID4045975
ECHA InfoCard	100.234.875
Chemical and physical data
Formula	C17H14F3N3O3S
Molar mass	397.37 g·mol−1
3D model (JSmol)	Interactive image
SMILES O=S(=O)(c3ccc(n1nc(cc1c2ccc(OC)c(F)c2)C(F)F)cc3)N
InChI InChI=1S/C17H14F3N3O3S/c1-26-16-7-2-10(8-13(16)18)15-9-14(17(19)20)22-23(15)11-3-5-12(6-4-11)27(21,24)25/h2-9,17H,1H3,(H2,21,24,25) Y Key:WAZQAZKAZLXFMK-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

Deracoxib (trade name Deramaxx) is a nonsteroidal anti-inflammatory drug (NSAID) of the coxib class, used in dogs to treat pain associated with osteoarthritis, or to prevent pain following orthopedic or dental surgery. It is available as beef-flavored tablets.^[1]